Jennifer J Rhodes Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jennifer J Rhodes.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jennifer J Rhodes. Jennifer J Rhodes is GC & Chief Compliance Officer in MEDIVATION, INC. ($MDVN) and GC & Corporate Secretary in MEDIVATION, INC. ($MDVN) and CBO, GC & Compliance Officer in Adamas Pharmaceuticals Inc ($ADMS) and General Counsel in Adamas Pharmaceuticals Inc ($ADMS) and See Remarks in Angion Biomedica Corp. ($ANG).
Latest Insider Trading Transactions of Jennifer J Rhodes
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADMS, ANG, MDVN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15 2021 | ANG | Angion Biomedica C ... | Rhodes Jennifer J | See Remarks | Sell | S | 15.01 | 399 | 5,989 | 33,887 | 34.3 K to 33.9 K (-1.16 %) |
| Mar 16 2021 | ANG | Angion Biomedica C ... | Rhodes Jennifer J | See Remarks | Sell | S | 20.45 | 499 | 10,205 | 34,286 | 34.8 K to 34.3 K (-1.43 %) |
| Feb 17 2021 | ANG | Angion Biomedica C ... | Rhodes Jennifer J | See Remarks | Sell | S | 19.54 | 457 | 8,930 | 34,785 | 35.2 K to 34.8 K (-1.30 %) |
| Feb 08 2021 | ANG | Angion Biomedica C ... | Rhodes Jennifer J | See Remarks | Option Exercise | A | 16.00 | 70,012 | 1,120,192 | 70,012 | |
| Jun 21 2019 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Sell | S | 5.35 | 940 | 5,029 | 63,114 | 64.1 K to 63.1 K (-1.47 %) |
| Apr 10 2019 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Option Exercise | A | 6.81 | 60,000 | 408,600 | 60,000 | |
| Apr 10 2019 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Grant | A | 0.00 | 30,000 | 0 | 61,612 | 31.6 K to 61.6 K (+94.90 %) |
| Mar 21 2019 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Sell | S | 7.99 | 1,792 | 14,318 | 31,612 | 33.4 K to 31.6 K (-5.36 %) |
| Dec 21 2018 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Sell | S | 7.52 | 425 | 3,196 | 33,404 | 33.8 K to 33.4 K (-1.26 %) |
| Jun 22 2018 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Sell | S | 25.48 | 1,002 | 25,531 | 33,794 | 34.8 K to 33.8 K (-2.88 %) |
| Mar 22 2018 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Sell | S | 25.89 | 982 | 25,424 | 34,128 | 35.1 K to 34.1 K (-2.80 %) |
| Mar 09 2018 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Option Exercise | A | 25.66 | 37,500 | 962,250 | 37,500 | |
| Mar 09 2018 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Grant | A | 0.00 | 6,250 | 0 | 35,110 | 28.9 K to 35.1 K (+21.66 %) |
| Dec 21 2017 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Sell | S | 32.30 | 440 | 14,212 | 28,860 | 29.3 K to 28.9 K (-1.50 %) |
| Jun 22 2017 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Sell | S | 17.53 | 1,041 | 18,254 | 28,455 | 29.5 K to 28.5 K (-3.53 %) |
| Jan 20 2017 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Option Exercise | A | 16.61 | 67,500 | 1,121,175 | 67,500 | |
| Jan 20 2017 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Grant | A | 0.00 | 11,250 | 0 | 27,187 | 15.9 K to 27.2 K (+70.59 %) |
| Nov 08 2016 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | General Counsel | Option Exercise | A | 14.26 | 28,125 | 401,063 | 28,125 | |
| Nov 08 2016 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | General Counsel | Grant | A | 0.00 | 4,687 | 0 | 15,937 | 11.3 K to 15.9 K (+41.66 %) |
| May 23 2016 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | General Counsel | Option Exercise | A | 14.70 | 67,500 | 992,250 | 67,500 | |
| May 23 2016 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | General Counsel | Grant | A | 0.00 | 11,250 | 0 | 11,250 | 0 to 11.3 K |
| Mar 17 2015 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Corporate Secr ... | Sell | S | 130.92 | 1,390 | 181,979 | 11,090 | 12.5 K to 11.1 K (-11.14 %) |
| Feb 27 2015 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Corporate Secr ... | Option Exercise | M | 47.48 | 2,000 | 94,960 | 40,000 | |
| Feb 27 2015 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Corporate Secr ... | Sell | S | 120.00 | 2,000 | 240,000 | 11,391 | 13.4 K to 11.4 K (-14.94 %) |
| Feb 27 2015 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Corporate Secr ... | Sell | S | 118.00 | 1,089 | 128,502 | 13,391 | 14.5 K to 13.4 K (-7.52 %) |
| Feb 27 2015 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Corporate Secr ... | Buy | M | 47.48 | 2,000 | 94,960 | 14,480 | 12.5 K to 14.5 K (+16.03 %) |
| Mar 02 2015 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Corporate Secr ... | Option Exercise | M | 47.48 | 2,000 | 94,960 | 38,000 | |
| Mar 02 2015 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Corporate Secr ... | Sell | S | 122.00 | 2,000 | 244,000 | 12,480 | 14.5 K to 12.5 K (-13.81 %) |
| Mar 02 2015 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Corporate Secr ... | Buy | M | 47.48 | 2,000 | 94,960 | 14,480 | 12.5 K to 14.5 K (+16.03 %) |
| Feb 18 2015 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Corporate Secr ... | Option Exercise | A | 105.33 | 19,000 | 2,001,270 | 19,000 | |
| Feb 11 2015 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Corporate Secr ... | Grant | A | 0.00 | 3,500 | 0 | 12,480 | 9 K to 12.5 K (+38.98 %) |
| Feb 06 2015 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Corporate Secr ... | Sell | S | 100.85 | 610 | 61,519 | 8,980 | 9.6 K to 9 K (-6.36 %) |
| Dec 04 2014 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Corporate Secr ... | Sell | S | 113.00 | 910 | 102,830 | 9,590 | 10.5 K to 9.6 K (-8.67 %) |
| Feb 20 2014 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Chief Complian ... | Option Exercise | A | 83.55 | 23,000 | 1,921,650 | 23,000 | |
| Feb 06 2014 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Chief Complian ... | Grant | A | 0.00 | 4,500 | 0 | 10,500 | 6 K to 10.5 K (+75.00 %) |
| Jan 23 2014 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Chief Complian ... | Option Exercise | M | 47.48 | 14,000 | 664,720 | 42,000 | |
| Jan 23 2014 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Chief Complian ... | Sell | S | 78.83 | 100 | 7,883 | 6,000 | 6.1 K to 6 K (-1.64 %) |
| Jan 23 2014 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Chief Complian ... | Sell | S | 78.14 | 100 | 7,814 | 6,100 | 6.2 K to 6.1 K (-1.61 %) |
| Jan 23 2014 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Chief Complian ... | Sell | S | 77.44 | 100 | 7,744 | 6,200 | 6.3 K to 6.2 K (-1.59 %) |
| Jan 23 2014 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Chief Complian ... | Sell | S | 76.66 | 4,300 | 329,638 | 6,300 | 10.6 K to 6.3 K (-40.57 %) |
| Jan 23 2014 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Chief Complian ... | Sell | S | 76.05 | 9,400 | 714,870 | 10,600 | 20 K to 10.6 K (-47.00 %) |
| Jan 23 2014 | MDVN | MEDIVATION, INC. | Rhodes Jennifer J | GC & Chief Complian ... | Sell | M | 47.48 | 14,000 | 664,720 | 20,000 | 34 K to 20 K (-41.18 %) |
Page: 1